EUVIMEDEUVIMED entdecken
Crossref

The Quest for Ligands Against Kinesin Motor Protein Eg5

Ahmet Fatih Sahin, Simone Carradori iD, Alessia Ricci, Muhammad Rashad iD, Atilla Akdemir iD

Archiv der Pharmazie · 2025-05 · 358 (5)

DOI: 10.1002/ardp.70010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 22.05.2025. Verfasst von Ahmet Fatih Sahin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Discovery and Development, Institute of Health Sciences, Bezmialem Vakif University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Kinesins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: This study was supported by TUBITAK (The Scientific and Technological Research Council of Turkey)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Kinesin Eg5 motor protein is essential for the formation of the mitotic spindles and chromosome segregation, which is necessary for cell division. The inhibition of Eg5 has emerged as a potential therapeutic strategy for inhibiting the uncontrolled proliferation of cancer cells. This study aims to identify inhibitors targeting the allosteric site I of Eg5. To this end, a hierarchical virtual screening was applied to screen the ZINC20‐Anodyne compound library comprising approximately 11 million druglike compounds. The procedure includes a shape similarity screening, a pharmacophore screening, docking studies with subsequent re‐scorings, molecular dynamics simulations, and Molecular Mechanics‐Generalized Born Surface Area (MM‐GBSA) binding free energy calculations and resulted in the selection of four compounds for Eg5 inhibition assays. One compound displays an IC 50 value of 29 µM, while the remaining three compounds show weaker inhibition of Kinesin Eg5. As such, structurally novel Kinesin Eg5 inhibitors have been obtained for further hit‐to‐lead optimization programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KinesinsLigandsStructure-Activity RelationshipMolecular Docking SimulationHumansMolecular Dynamics SimulationDose-Response Relationship, DrugMolecular Structure

Stichwörter der Autor:innen

Kinesin Eg5 motor proteincancerinhibition assaysmolecular dynamics simulationsvirtual screening

Substanzen

KinesinsKIF11 protein, humanLigands

Autor:innen und Institutionen

  • Department of Drug Discovery and Development, Institute of Health Sciences, Bezmialem Vakif University, Istanbul, Turkey.
  • Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Department of Pharmacology, Faculty of Pharmacy, Istinye University, Istanbul, Turkey.

ORCID-Profile: Simone Carradori, Muhammad Rashad, Atilla Akdemir

Förderung

  • This study was supported by TUBITAK (The Scientific and Technological Research Council of Turkey).

Zitieren

APA

Sahin, A. F., Carradori, S., Ricci, A., Rashad, M., & Akdemir, A. (2025). The Quest for Ligands Against Kinesin Motor Protein Eg5. Archiv der Pharmazie, 358(5). https://doi.org/10.1002/ardp.70010

Vancouver

Sahin AF, Carradori S, Ricci A, Rashad M, Akdemir A. The Quest for Ligands Against Kinesin Motor Protein Eg5. Archiv der Pharmazie. 2025;358(5). doi:10.1002/ardp.70010

BibTeX
@article{Sahin2025,
  author = {Sahin, Ahmet Fatih and Carradori, Simone and Ricci, Alessia and Rashad, Muhammad and Akdemir, Atilla},
  title = {The Quest for Ligands Against Kinesin Motor Protein Eg5},
  journal = {Archiv der Pharmazie},
  year = {2025},
  volume = {358},
  number = {5},
  doi = {10.1002/ardp.70010}
}
Kostenlos starten →